ArticleMolecules (Basel, Switzerland)2026
Optimisation and Validation of a Quantitative Method for the Analysis of Polymers of Nanoplastics in Human Faeces.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Concerns about human exposure to micro- and nanoplastics (MNPLs), particularly nanoplastics (NPLs), have intensified in recent years. Consequently, there is a growing need for validated quantitative analytical methods capable of assessing NPLs in complex human biological matrices. Current approaches for NPL analysis are still limited by the absence of standardised protocols, difficulties in avoiding background contamination, and challenges associated with the selective identification and quantification of polymer-specific nanoparticles. Moreover, most common approaches for quantification by particle counting cannot be applied for NPLs < 500 nm. In this study, we developed and validated an analytical method for the detection and quantification of NPLs in human faeces. As an initial step, polyethylene (PE) and polypropylene (PP) nanoparticles (NPs) were synthesised using bottom-up methods and characterised by dynamic light scattering (DLS) and electron microscopy (SEM and TEM). To optimise and assess the extraction, synthetic faeces were prepared and used in spiking experiments to avoid background contamination from plastics. Two digestion strategies were evaluated: (i) Fenton's reagent followed by strong acid digestion, and (ii) alkaline digestion. Quantitative determination of polymer-specific NPLs was performed by size-exclusion liquid chromatography coupled with high-resolution mass spectrometry and atmospheric-pressure photoionization (SEC-APPI-HRMS). Polymer identification was based on characteristic monomer-loss patterns and Kendrick Mass Defect analysis. Fenton-based digestion showed superior performance, yielding recoveries about 55-66% for PE and 59-61% for PP. The validated method achieved limits of detection and quantification of 0.015 and 0.058 μg/kg for PE, and 0.025 and 0.083 μg/kg for PP, respectively. Precision, expressed as %RSD, was 10.1% for PE and 20.1% for PP. These results demonstrate that SEC-APPI-HRMS combined with Fenton-based digestion provides a sensitive and reliable approach for the quantification of polymer-specific NPLs in human faeces. The method represents an important advance for human biomonitoring studies and supports future research aimed at assessing human exposure and the potential health risks associated with nanoplastics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.